Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rescuing the attentional performance of rats with cholinergic losses by the M1 positive allosteric modulator TAK-071
Aaron Kucinski, Kyra B. Phillips, Ajeesh Koshy Cherian, et al.
Psychopharmacology (2019) Vol. 237, Iss. 1, pp. 137-153
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

An Acetylcholine M1 Receptor–Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment
Niraj M. Shanbhag, Jaya Padmanabhan, Zheng Zhang, et al.
JAMA Neurology (2025)
Closed Access | Times Cited: 2
Forebrain Cholinergic Signaling: Wired and Phasic, Not Tonic, and Causing Behavior
Martin Sarter, Cindy Lustig
Journal of Neuroscience (2020) Vol. 40, Iss. 4, pp. 712-719
Open Access | Times Cited: 99
Targeting muscarinic receptors to treat schizophrenia
Daniel J. Foster, Zoey Bryant, P. Jeffrey Conn
Behavioural Brain Research (2021) Vol. 405, pp. 113201-113201
Open Access | Times Cited: 67
Muscarinic M1 and M4 receptors: Hypothesis driven drug development for schizophrenia
Brian Dean, Elizabeth Scarr
Psychiatry Research (2020) Vol. 288, pp. 112989-112989
Closed Access | Times Cited: 56
Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics
Divya Yadav, Pravir Kumar
Neurochemistry International (2022) Vol. 156, pp. 105327-105327
Closed Access | Times Cited: 32
M 1 -selective muscarinic allosteric modulation enhances cognitive flexibility and effective salience in nonhuman primates
Seyed A. Hassani, Adam Neumann, Jason K Russell, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 18
Open Access | Times Cited: 12
Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson’s disease
Nicola Ray, Rachael Lawson, Sarah L. Martin, et al.
Brain (2022) Vol. 146, Iss. 3, pp. 1053-1064
Open Access | Times Cited: 17
Complex Movement Control in a Rat Model of Parkinsonian Falls: Bidirectional Control by Striatal Cholinergic Interneurons
Cassandra Avila, Aaron Kucinski, Martin Sarter
Journal of Neuroscience (2020) Vol. 40, Iss. 31, pp. 6049-6067
Open Access | Times Cited: 24
Make a Left Turn: Cortico‐Striatal Circuitry Mediating the Attentional Control of Complex Movements
Martin Sarter, Cassandra Avila, Aaron Kucinski, et al.
Movement Disorders (2021) Vol. 36, Iss. 3, pp. 535-546
Open Access | Times Cited: 21
Stress Regulation of Sustained Attention and the Cholinergic Attention System
Samantha R. Eck, Song‐Jun Xu, Alexander M. Telenson, et al.
Biological Psychiatry (2020) Vol. 88, Iss. 7, pp. 566-575
Open Access | Times Cited: 23
Modulation of the p75NTR during Adolescent Alcohol Exposure Prevents Cholinergic Neuronal Atrophy and Associated Acetylcholine Activity and Behavioral Dysfunction
Brian T. Kipp, Lisa M. Savage
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5792-5792
Open Access | Times Cited: 2
IUPHAR Review on muscarinic M1 and M4 receptors as drug treatment targets relevant to the molecular pathology of schizophrenia.
Brian Dean
Pharmacological Research (2024) Vol. 210, pp. 107510-107510
Open Access | Times Cited: 2
Safety, pharmacokinetics and quantitative EEG modulation of TAK‐071, a novel muscarinic M1 receptor positive allosteric modulator, in healthy subjects
Wei Yin, Fahimeh Mamashli, Derek L. Buhl, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 2, pp. 600-612
Open Access | Times Cited: 15
Muscarinic M1 and M4 receptor agonists for schizophrenia: promising candidates for the therapeutic arsenal
Brian Dean
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 12, pp. 1113-1121
Closed Access | Times Cited: 6
Reduction of falls in a rat model of PD falls by the M1 PAM TAK-071
Aaron Kucinski, Martin Sarter
Psychopharmacology (2021) Vol. 238, Iss. 7, pp. 1953-1964
Open Access | Times Cited: 11
Co-stimulation of muscarinic M1 and M4 acetylcholine receptors prevents later cocaine reinforcement in male and female mice, but not place-conditioning
Abhishek Shankar Balakrishnan, Lærke Bornø Engelhardt Johansen, Craig W. Lindsley, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 134, pp. 111079-111079
Open Access | Times Cited: 1
Methylmercury, attention, and memory: baseline-dependent effects of adult d-amphetamine and marginal effects of adolescent methylmercury
Dalisa R. Kendricks, Steven R. Boomhower, M. Christopher Newland
NeuroToxicology (2020) Vol. 80, pp. 130-139
Open Access | Times Cited: 9
Forebrain Cholinergic Signaling: Wired and Phasic, not Tonic, and Causing Behavior
Martin Sarter, Cindy Lustig
(2019)
Open Access | Times Cited: 9
Modern synthesis of cognitive enhancers: cholinergic ligands
Fedor V. Ryzhkov, Yuliya E. Ryzhkova, Michaïl N. Elinson, et al.
Russian Chemical Bulletin (2023) Vol. 72, Iss. 4, pp. 819-837
Closed Access | Times Cited: 3
Modes of Acetylcholine Signaling in the Prefrontal Cortex: Implications for Cholinergic Dysfunction and Disorders
Matthew J. Fecik, Lisa M. Savage
IntechOpen eBooks (2023)
Open Access | Times Cited: 2
Modulation of the p75NTR during adolescent alcohol exposure prevents cholinergic neuronal atrophy and associated acetylcholine activity and behavioral dysfunction
Brian T. Kipp, M. Lisa
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The middle managers: thalamic and cholinergic contributions to coordinating top-down and bottom-up processing
Cindy Lustig, Nicolaas I. Bohnen
Current Opinion in Behavioral Sciences (2024) Vol. 58, pp. 101406-101406
Closed Access
Visual hallucinations in Parkinson's disease: spotlight on central cholinergic dysfunction
Anna Ignatavicius, Elie Matar, Simon J.G. Lewis
Brain (2024) Vol. 148, Iss. 2, pp. 376-393
Open Access
LRRK2 mutation contributes to decreased free water in the nucleus basalis of Meynert in manifest and premanifest Parkinson’s disease
Chao Wang, Shuyue Wang, Cheng Zhou, et al.
Journal of Neurology (2024) Vol. 272, Iss. 1
Closed Access
Acetylcholine - Recent Advances and New Perspectives

IntechOpen eBooks (2023)
Open Access
Page 1 - Next Page

Scroll to top